StockData
Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc. (RCKT) stock

RCKTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$2.11−0.05 (-2.31%)

Close on Nov 17, 2026Market cap $231.62MP/E –Yield –

Rocket Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Rocket Pharmaceuticals's EV/EBITDA was 3.0× on Jan 31, 2018.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2018Jan 31, 20183.0×–

More Rocket Pharmaceuticals figures

See a number that looks wrong?